🎯 check Eganelisib (IPI-549) product page
Eganelisib (IPI-549) is a selective PI3Kγ inhibitor. It affects PI3K/AKT/MAPK signaling by downregulating AKT phosphorylation, effectively promoting T cell expansion, driving M1 macrophage polarization, and alleviating MDSC-mediated immunosuppression.